Maria A Hawkins (Maria Hawkins, M A Hawkins)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Topics

Helicobacter Pylori Infection

Small Cell Lung Cancer

Top Venues

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

S R Javed, Simon R Lord, S El Badri, R Harman, J Holmes, F Kamzi, Timothy S Maughan, David McIntosh, S Mukherjee, A Ooms, G Radhakrishna, P Shaw, Maria A Hawkins
CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method. British journal of cancer 130 (3) (2023)
S R Javed, Simon R Lord, S El Badri, R Harman, J Holmes, F Kamzi, Timothy S Maughan, David McIntosh, S Mukherjee, A Ooms, G Radhakrishna, P Shaw, Maria A Hawkins
CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method. British journal of cancer 130 (3) (2023)
S R Javed, Simon R Lord, S El Badri, R Harman, J Holmes, F Kamzi, Timothy S Maughan, David McIntosh, S Mukherjee, A Ooms, G Radhakrishna, P Shaw, Maria A Hawkins
CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method. British journal of cancer 130 (3) (2023)
S R Javed, Simon R Lord, S El Badri, R Harman, J Holmes, F Kamzi, Timothy S Maughan, David McIntosh, S Mukherjee, A Ooms, G Radhakrishna, P Shaw, Maria A Hawkins
CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method. British journal of cancer (2023)
S R Javed, Simon R Lord, S El Badri, R Harman, J Holmes, F Kamzi, Timothy S Maughan, David McIntosh, S Mukherjee, A Ooms, G Radhakrishna, P Shaw, Maria A Hawkins
CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method. British journal of cancer 130 (3) (2023)
S R Javed, Simon R Lord, S El Badri, R Harman, J Holmes, F Kamzi, Timothy S Maughan, David McIntosh, S Mukherjee, A Ooms, G Radhakrishna, P Shaw, Maria A Hawkins
CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method. British journal of cancer 130 (3) (2023)
S R Javed, Simon R Lord, S El Badri, R Harman, J Holmes, F Kamzi, Timothy S Maughan, David McIntosh, S Mukherjee, A Ooms, G Radhakrishna, P Shaw, Maria A Hawkins
CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method. British journal of cancer 130 (3) (2023)
S R Javed, Simon R Lord, S El Badri, R Harman, J Holmes, F Kamzi, Timothy S Maughan, David McIntosh, S Mukherjee, A Ooms, G Radhakrishna, P Shaw, Maria A Hawkins
CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method. British journal of cancer 130 (3) (2023)
Eleanor M Hudson, Samantha Noutch, Sarah R Brown, Ravi Adapala, Simon P Bach, Carole Burnett, Alwyn Burrage, Alexandra Gilbert, Maria A Hawkins, Debra Howard, Monica Jefford, Rohit Kochhar, Mark Saunders, Jenny Seligmann, Alexandra Smith, Mark Teo, Edward J D Webb, Amanda Webster, Nicholas West, David Sebag-Montefiore, Simon Gollins, Ane L Appelt
A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial. BMJ open 12 (4) (2022)
Edward Chandy, Adam Szmul, Alkisti Stavropoulou, Joseph Jacob, Catarina Veiga, David Landau, James Wilson, Sarah Gulliford, John D Fenwick, Maria A Hawkins, Crispin Hiley, Jamie R McClelland
Quantitative Analysis of Radiation-Associated Parenchymal Lung Change. Cancers 14 (4) (2022)
Huei-Tyng Huang, Michael G Nix, Douglas H Brand, David Cobben, Crispin T Hiley, John D Fenwick, Maria A Hawkins
Dose-Response Analysis Describes Particularly Rapid Repopulation of Non-Small Cell Lung Cancer during Concurrent Chemoradiotherapy. Cancers 14 (19) (2022)